BR112013033125A8 - Sistema de ligação que aumenta seletivamente a biotividade de compostos fenólicos em um sítio alvo; par de reagentes estabilizados para transporte aquoso a um sítio alvo; formulação farmacêutica; kit; uso do sistema; composição; e suplemento alimentar - Google Patents
Sistema de ligação que aumenta seletivamente a biotividade de compostos fenólicos em um sítio alvo; par de reagentes estabilizados para transporte aquoso a um sítio alvo; formulação farmacêutica; kit; uso do sistema; composição; e suplemento alimentarInfo
- Publication number
- BR112013033125A8 BR112013033125A8 BR112013033125A BR112013033125A BR112013033125A8 BR 112013033125 A8 BR112013033125 A8 BR 112013033125A8 BR 112013033125 A BR112013033125 A BR 112013033125A BR 112013033125 A BR112013033125 A BR 112013033125A BR 112013033125 A8 BR112013033125 A8 BR 112013033125A8
- Authority
- BR
- Brazil
- Prior art keywords
- target site
- kit
- composition
- food supplement
- phenolic compounds
- Prior art date
Links
- 150000002989 phenols Chemical class 0.000 title abstract 4
- 235000015872 dietary supplement Nutrition 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003642 reactive oxygen metabolite Substances 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 206010017943 Gastrointestinal conditions Diseases 0.000 abstract 1
- 102000004316 Oxidoreductases Human genes 0.000 abstract 1
- 108090000854 Oxidoreductases Proteins 0.000 abstract 1
- 206010000059 abdominal discomfort Diseases 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000001147 anti-toxic effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Food Science & Technology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
Abstract
SISTEMA DE LIGAÇÃO PARA UTILIZAÇÃO NA MORTE DE BACTÉRIAS RESISTENTES AOS ANTIBIÓTICOS; KIT; USO DO SISTEMA; COMPOSIÇÃO; E SUPLEMENTO ALIMENTAR. Os ensinamentos aqui providos se referem de modo geral, a sistemas de ligação acionados no local que, de maneira seletiva, aumentam a bioatividade de compostos fenólicos em locais alvo. Os sistemas podem incluir um composto fenólico ligado a uma espécie reativa de oxigênio, em que o composto fenólico e a espécie reativa de oxigênio podem reagir em uma área alvo na presença de uma enzima oxidorredutase. Os sistemas podem ser utilizados, por exemplo, como uma antitoxina, um antiinflamatório ou um antimicrobiano. Os usos podem incluir o tratamento de uma condição gastrointestinal, um tecido dérmico danificado, ou um tecido da mucosa danificado, assim como na promoção de saúde gastrointestinal que pode, por exemplo, resultar no alívio de desconforto gastrointestinal ou, talvez, criando um ganho de peso em um animal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/135,124 US8722040B2 (en) | 2011-06-24 | 2011-06-24 | Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites |
PCT/US2012/043900 WO2012178127A2 (en) | 2011-06-24 | 2012-06-22 | Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112013033125A2 BR112013033125A2 (pt) | 2017-01-24 |
BR112013033125A8 true BR112013033125A8 (pt) | 2023-02-07 |
Family
ID=47362044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013033125A BR112013033125A8 (pt) | 2011-06-24 | 2012-06-22 | Sistema de ligação que aumenta seletivamente a biotividade de compostos fenólicos em um sítio alvo; par de reagentes estabilizados para transporte aquoso a um sítio alvo; formulação farmacêutica; kit; uso do sistema; composição; e suplemento alimentar |
Country Status (17)
Country | Link |
---|---|
US (6) | US8722040B2 (pt) |
EP (2) | EP2723334A4 (pt) |
JP (3) | JP2014523883A (pt) |
KR (1) | KR20140061368A (pt) |
CN (2) | CN103764141A (pt) |
AU (2) | AU2012272661B2 (pt) |
BR (1) | BR112013033125A8 (pt) |
CA (1) | CA2840376A1 (pt) |
CO (1) | CO6862156A2 (pt) |
HK (2) | HK1197177A1 (pt) |
MX (1) | MX2013015439A (pt) |
MY (1) | MY189659A (pt) |
PH (1) | PH12018501201A1 (pt) |
RU (1) | RU2014101570A (pt) |
SG (1) | SG10201809283WA (pt) |
WO (1) | WO2012178127A2 (pt) |
ZA (1) | ZA201400532B (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011500733A (ja) | 2007-10-26 | 2011-01-06 | ケマファー インコーポレーテッド | 免疫応答を増強するための組成物および方法 |
US8734867B2 (en) | 2007-12-28 | 2014-05-27 | Liveleaf, Inc. | Antibacterial having an extract of pomegranate combined with hydrogen peroxide |
WO2010101844A1 (en) * | 2009-03-04 | 2010-09-10 | Metaactiv, Inc. | Method and material for site activated complexing of biologic molecules |
CA2771204C (en) | 2009-04-30 | 2017-09-19 | Chemaphor Inc. | Methods and compositions for improving the health of animals |
US9192635B2 (en) | 2011-06-24 | 2015-11-24 | Liveleaf, Inc. | Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide |
US8722040B2 (en) | 2011-06-24 | 2014-05-13 | Liveleaf, Inc. | Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites |
CA3026687A1 (en) | 2012-03-21 | 2013-09-26 | Galleon Labs Llc | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
US9283241B2 (en) * | 2012-07-10 | 2016-03-15 | Clemson University | Treatment to render implants resistant to diabetes |
US9526754B1 (en) * | 2012-11-26 | 2016-12-27 | Manuel Serrano | Plant polyphenols extraction and activation thereof |
US8716351B1 (en) | 2012-12-23 | 2014-05-06 | Liveleaf, Inc. | Methods of treating gastrointestinal spasms |
CN103223045A (zh) * | 2013-04-08 | 2013-07-31 | 张宗升 | 中药组合物 |
CN103462987B (zh) * | 2013-08-19 | 2015-11-18 | 江汉大学 | 表没食子儿茶素没食子酸酯硬脂酸酯的应用以及一种治疗银屑病的药物组合物 |
US20160250253A1 (en) * | 2013-09-24 | 2016-09-01 | Cosmederm Bioscience, Inc. | Strontium-containing complexes for treating gastroesophageal reflux and barrett's esophagus |
WO2015102003A1 (en) * | 2014-01-05 | 2015-07-09 | Bioharvest Ltd. | Pomegranate derived cell culture and methods for preparing and using the same |
US20170112877A1 (en) * | 2014-06-13 | 2017-04-27 | Alexander L. Huang | Non-toxic agent for a broad-spectrum, bactericidal or bacteriostatic treatment of antibiotic-resistant bacteria in animals |
US9173915B1 (en) * | 2014-10-10 | 2015-11-03 | Peter F. Kador | Antioxidant eye drops |
KR20170140298A (ko) * | 2015-04-28 | 2017-12-20 | 아비바젠 인코포레이티드. | 괴사성 장염 예방용 산화 카로티노이드 및 이의 성분 |
US10945974B2 (en) * | 2015-06-01 | 2021-03-16 | Xeno Biosciences Inc. | Methods and compositions to modulate the gut microbiota and to manage weight |
US11235002B2 (en) | 2015-08-21 | 2022-02-01 | Galleon Labs Llc | Strontium based compositions and formulations for pain, pruritus, and inflammation |
EP3439619A1 (en) * | 2016-04-07 | 2019-02-13 | University College Dublin, National University of Ireland, Dublin | Treatment of inflammatory bowel disease |
JP6918839B2 (ja) * | 2016-05-20 | 2021-08-11 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 概日時計の乱れに関連するマイクロバイオームの調節異常を処置するための方法及び医薬組成物 |
US11959125B2 (en) | 2016-09-15 | 2024-04-16 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
US20180112578A1 (en) | 2016-10-24 | 2018-04-26 | Ngk Insulators, Ltd. | Porous material, honeycomb structure, and manufacturing method of porous material |
KR102010475B1 (ko) * | 2016-12-12 | 2019-08-13 | 친환경시험원 주식회사 | 성게류 회피도료 및 이의 제조방법 |
EP3675813A4 (en) * | 2017-08-28 | 2021-03-24 | Global Biolife Inc. | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS |
EP4110269A4 (en) * | 2020-02-28 | 2024-01-17 | Univ Emory | PENTAGALLOYL GLUCOSE DERIVED FROM SCHINUS PLANTS AND METHODS OF USE |
US20230340625A1 (en) * | 2020-04-13 | 2023-10-26 | Sun Genomics, Inc. | Method and system for detecting and treating exposure to an infectious pathogen |
Family Cites Families (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1844018A (en) | 1929-04-18 | 1932-02-09 | Mead Res Engineering Company | Method of preparing tanning substances |
DE530650C (de) | 1930-12-09 | 1931-07-31 | Hoffmann La Roche & Co Akt Ges | Verfahren zur Herstellung von Protocatechualdehyd und seinen Substitutionsprodukten |
US1965458A (en) | 1932-05-18 | 1934-07-03 | Hoffmann La Roche | Process for the manufacture of aromatic hydroxy aldehydes |
US3484248A (en) | 1967-07-03 | 1969-12-16 | Lipton Inc Thomas J | Alkaline conversion of green tea using hydrogen peroxide |
GB1204585A (en) | 1968-01-23 | 1970-09-09 | Tenco Brooke Bond Ltd | Improvements in or relating to the fermentation of tea |
US3817835A (en) | 1969-03-26 | 1974-06-18 | Squibb & Sons Inc | Process for the production of antimicrobial agents |
US3692904A (en) | 1970-05-25 | 1972-09-19 | Daiichi Seiyaku Co | Method for treating scours in domestic livestock |
US3824184A (en) | 1970-09-04 | 1974-07-16 | Economics Lab | Slime control in industrial waters |
GB1377396A (en) | 1971-04-26 | 1974-12-18 | Unilever Ltd | Instant tea powder |
IT986371B (it) | 1972-06-02 | 1975-01-30 | Degussa | Procedimento per la produzione di percarbonato alcalino |
US3860694A (en) | 1972-08-31 | 1975-01-14 | Du Pont | Process for the preparation of perhydrates |
JPS5429599B2 (pt) | 1974-12-28 | 1979-09-25 | ||
SE7601543L (sv) | 1975-02-21 | 1976-08-23 | Snam Progetti | Forfarande for extrahering av fenoler och oligosackarider ur vegetabiliskt material |
US4171280A (en) | 1977-11-03 | 1979-10-16 | The Clorox Company | Powder percarbonate bleach and formation thereof |
US4514334A (en) | 1979-05-31 | 1985-04-30 | General Electric Company | Polyphenolic compounds |
FR2486523A1 (fr) | 1980-07-11 | 1982-01-15 | Rhone Poulenc Ind | Procede de preparation de polyphenols comportant eventuellement un groupement aldehyde |
US4623465A (en) | 1981-04-20 | 1986-11-18 | Massachusetts Institute Of Technology | Removal of combined organic substances from aqueous solutions |
US4472302A (en) | 1983-03-09 | 1984-09-18 | Merck & Co., Inc. | Heat shock process for the isolation of bacterial protein |
US4472602A (en) | 1983-08-11 | 1984-09-18 | At&T Technologies, Inc. | Telephone set with transducer/ringer |
US5141611A (en) | 1985-05-16 | 1992-08-25 | Memtec Limited | Removing and recovering plant polyphenols |
US4829001A (en) | 1985-11-08 | 1989-05-09 | Minnesota Mining And Manufacturing Company | Enzymatic neutralization of hydrogen peroxide |
US4647952A (en) | 1985-11-13 | 1987-03-03 | The Mead Corporation | Phenolic developer resins |
US5296376A (en) | 1986-11-04 | 1994-03-22 | Imperial Chemical Industries Plc | DNA, constructs, cells and plants derived therefrom |
US4966762A (en) | 1988-10-06 | 1990-10-30 | Fmc Corporation | Process for manufacturing a soda ash peroxygen carrier |
US5231193A (en) | 1989-03-29 | 1993-07-27 | Kikkoman Corporation | Process for producing ellagic acid |
JPH0791302B2 (ja) | 1989-03-29 | 1995-10-04 | キッコーマン株式会社 | エラグ酸の製造法 |
JP3005012B2 (ja) * | 1990-02-23 | 2000-01-31 | 三井農林株式会社 | 抗生物質耐性ブドウ球菌感染予防剤 |
US5756090A (en) | 1991-02-21 | 1998-05-26 | Eoe, Inc. | Oxygen activatable formulations for disinfection or sterilization |
US5389369A (en) | 1991-02-21 | 1995-02-14 | Exoxemis, Inc. | Halo peroxidase containing compositions for killing yeast and sporular microorganisms |
US5208010A (en) | 1991-06-17 | 1993-05-04 | Dental Concepts Inc. | Tooth whitening dentifrice |
US5260021A (en) | 1992-06-29 | 1993-11-09 | Allergan, Inc. | Hydrogen peroxide-containing gels and contact lens disinfecting using same |
JPH07503376A (ja) | 1992-07-30 | 1995-04-13 | ケイヘーネ・エヌ・ベー | Dna構築物並びにそれから誘導される細胞及び植物 |
DK144392D0 (da) | 1992-12-01 | 1992-12-01 | Novo Nordisk As | Aktivering af enzymer |
US5328706A (en) | 1993-04-29 | 1994-07-12 | Endico Felix W | Food manufacturing process utilizing hydrogen peroxide for microbial control |
US6068862A (en) | 1993-06-30 | 2000-05-30 | Taiyo Kagaku Co., Ltd. | Tea-derived feed additive and animal feed containing the same |
US5653746A (en) | 1994-03-08 | 1997-08-05 | Meadox Medicals, Inc. | Radially expandable tubular prosthesis |
US5661170A (en) | 1994-03-21 | 1997-08-26 | Woodward Laboratories, Inc. | Antimicrobial compositions and methods for using the same |
US5614501A (en) | 1994-07-21 | 1997-03-25 | The University Of Montana | Compositions and methods for animal husbandry and for treating gastrointestinal disorders |
JP3245307B2 (ja) * | 1994-07-26 | 2002-01-15 | 三井農林株式会社 | 抗菌剤 |
TW449485B (en) | 1995-03-31 | 2001-08-11 | Colgate Palmolive Co | Skin care products containing anti itching/anti irritant agents |
US5824414A (en) | 1995-04-28 | 1998-10-20 | Mitsui Chemicals, Inc. | Preparation of spherical polyphenol particles |
US5839369A (en) | 1995-10-20 | 1998-11-24 | Eastman Kodak Company | Method of controlled laser imaging of zirconia alloy ceramic lithographic member to provide localized melting in exposed areas |
US6063428A (en) | 1996-02-26 | 2000-05-16 | The Procter & Gamble Company | Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color |
US6297273B1 (en) * | 1996-04-02 | 2001-10-02 | Mars, Inc. | Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions |
JP3320307B2 (ja) | 1996-06-06 | 2002-09-03 | 株式会社エス・ディー・エス バイオテック | フェノール性化合物等の高分子化方法及びその利用 |
US6642277B1 (en) | 1996-09-20 | 2003-11-04 | The Howard Foundation | Food supplements containing polyphenols |
EP0935417B1 (en) | 1996-10-16 | 2009-05-06 | Napo Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
US6436342B1 (en) | 1996-11-13 | 2002-08-20 | The Procter & Gamble Company | Sprayable disinfecting compositions and processes for disinfecting surfaces therewith |
WO1998023716A2 (en) | 1996-11-25 | 1998-06-04 | Unilever N.V. | Enzymatic oxidation process |
US5891440A (en) | 1996-12-31 | 1999-04-06 | Lansky; Ephraim Philip | Phytoestrogen supplement prepared from pomegranate seeds and a herbal mixture or coconut milk |
GB9721139D0 (en) | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
JP4137224B2 (ja) | 1998-03-31 | 2008-08-20 | 天野エンザイム株式会社 | 酵素による蛋白質の架橋法 |
US6071541A (en) | 1998-07-31 | 2000-06-06 | Murad; Howard | Pharmaceutical compositions and methods for managing skin conditions |
WO2000020406A1 (en) | 1998-10-06 | 2000-04-13 | Research Development Foundation | ANTIBACTERIAL AND ANTIFUNGAL FLAVANONES FROM $i(EYSENHARDTIA TEXANA) |
US20030078212A1 (en) | 1998-10-30 | 2003-04-24 | Jia-He Li | Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
US6630163B1 (en) | 1999-04-22 | 2003-10-07 | Howard Murad | Method of treating dermatological disorders with fruit extracts |
JP2000328443A (ja) * | 1999-05-18 | 2000-11-28 | Ito En Ltd | 茶ポリフェノール固着繊維の抗菌用途 |
US7297344B1 (en) | 1999-05-27 | 2007-11-20 | Euro-Celtique, S.A. | Preparations for the promotion of wound healing in the upper respiratory tract and/or ear |
US7504251B2 (en) | 1999-06-03 | 2009-03-17 | Biobalance Llc | Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
US6242010B1 (en) * | 1999-07-21 | 2001-06-05 | Thione International, Inc. | Synergistic antioxidant compositions in management of hemorrhoids and other ano-rectal inflammatory conditions |
GB9918028D0 (en) | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
KR100366608B1 (ko) | 2000-02-15 | 2003-01-09 | 마스터진(주) | 형질전환 식물체로부터 생산된 재조합 인간 파필로마바이러스 백신 |
US20020034553A1 (en) | 2000-09-19 | 2002-03-21 | Janice Zayas | Skin healing, conditioning and enhancing lotion |
US7381427B2 (en) | 2001-02-09 | 2008-06-03 | Mickey Miller | Seborrheic keratosis treatment |
US20030044474A1 (en) | 2001-08-03 | 2003-03-06 | Shaklee Corporation | High molecular weight, lipophilic, orally ingestible bioactive agents in formulations having improved bioavailability |
EP1312412B1 (en) | 2001-11-20 | 2013-03-13 | Mitsubishi Gas Chemical Company, Inc. | Process for producing hydrogen-containing gas |
US20040001665A1 (en) | 2002-07-01 | 2004-01-01 | Majd Zoorob | Optical device |
WO2004050795A2 (en) | 2002-11-27 | 2004-06-17 | Tufts University | Antioxidant-functionalized polymers |
US20040228831A1 (en) | 2003-05-15 | 2004-11-18 | Belinka Benjamin A. | Polymeric conjugates for tissue activated drug delivery |
US20080118602A1 (en) | 2004-01-16 | 2008-05-22 | Venkatraj Venkatrao Narayanan | Process for the Manufacture of a Tea Product and Products Obtained Thereby |
CA2559813A1 (en) | 2004-03-16 | 2005-09-22 | Combi Co. | Antidiarrheal agent for livestock and poultry |
CN1956726B (zh) | 2004-03-23 | 2011-04-13 | 生命线营养健康公司 | 用于缓解哺乳动物炎症及氧化应激的组合物和方法 |
WO2005099721A2 (en) | 2004-04-15 | 2005-10-27 | The Regents Of The University Of California | Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof |
US20060024385A1 (en) | 2004-07-27 | 2006-02-02 | Pedersen Mark A | Metabolic capacity enhancing compositions and methods for use in a mammal |
US20060024339A1 (en) | 2004-07-29 | 2006-02-02 | Howard Murad | Methods of managing the redness associated with a dermatological condition |
WO2006038893A1 (en) | 2004-10-06 | 2006-04-13 | Agency For Science, Technology And Research | Oxidation of phenolic compound with hydrogen peroxide generated in the presence of the phenolic compound |
US20060165812A1 (en) | 2005-01-21 | 2006-07-27 | Amershire Investment Corporation | Method and topical formulation for treating headaches |
US8128967B2 (en) | 2005-03-08 | 2012-03-06 | Mitsui Norin Co., Ltd. | Polyphenol coxib combinations and methods |
CN101291579A (zh) | 2005-05-27 | 2008-10-22 | 中央佛罗里达大学研究基金会有限公司 | 阿米巴病的植物疫苗 |
WO2007003068A1 (fr) | 2005-06-30 | 2007-01-11 | Hangzhou Lixin Biotechnology Co. Ltd. | Additif pour nourriture, procédé de préparation de celui-ci et application de celui-ci |
JP5167461B2 (ja) * | 2005-09-16 | 2013-03-21 | 国立医薬品食品衛生研究所長 | 炎症性腸疾患予防剤 |
US20070110812A1 (en) | 2005-11-14 | 2007-05-17 | Bausch & Lomb Incorporated | Ophthalmic composition for dry eye therapy |
WO2007079331A2 (en) | 2005-12-13 | 2007-07-12 | Richard Paul Bonfiglio | Antibacterial oral rinse formulation for preventing coronary artery disease |
US20090093440A1 (en) | 2005-12-20 | 2009-04-09 | Howard Murad | Fragranced Therapeutic Delivery System |
US20080194518A1 (en) * | 2005-12-23 | 2008-08-14 | MOOKERJEE Pradip | Antimicrobial Compositions |
WO2007090096A2 (en) | 2006-01-27 | 2007-08-09 | Rdx Technologies, Inc. | Electrochemical methods for redox control to preserve, stabilize and activate compounds |
US20100278759A1 (en) | 2006-02-08 | 2010-11-04 | Howard Murad | Topical Therapeutic Delivery System |
AU2007248182B2 (en) | 2006-05-01 | 2013-05-23 | Napo Pharmaceuticals, Inc. | Method for treatment of constipation-predominant irritable bowel syndrome |
US20080003314A1 (en) | 2006-06-29 | 2008-01-03 | Indivi Wine Usa, Llc | Germinated seeds possessing increased water-soluble polyphenols and method of manufacturing |
WO2008079898A1 (en) | 2006-12-20 | 2008-07-03 | Pharmwest, Inc. | Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions |
CA2696438C (en) | 2007-08-16 | 2015-12-08 | The University Of Chicago | The use of azelaic acid for priming a plant to induce a resistance response against a pathogen |
US8734867B2 (en) | 2007-12-28 | 2014-05-27 | Liveleaf, Inc. | Antibacterial having an extract of pomegranate combined with hydrogen peroxide |
WO2009114810A2 (en) * | 2008-03-14 | 2009-09-17 | The Florida International Uinversity Board Of Trustees | Use of ellagitannins as inhibitors of bacterial quorum sensing |
WO2010018418A1 (en) | 2008-08-12 | 2010-02-18 | Novatech D.O.O. | Formulation based on micronized clinoptilolite as therapeutic agent providing highly bioavailable silicon |
JP4811454B2 (ja) * | 2008-12-02 | 2011-11-09 | 村田機械株式会社 | 搬送台車システム及び搬送台車への走行経路の指示方法 |
WO2010101844A1 (en) | 2009-03-04 | 2010-09-10 | Metaactiv, Inc. | Method and material for site activated complexing of biologic molecules |
WO2010138082A1 (en) * | 2009-05-29 | 2010-12-02 | Agency For Science, Technology And Research | Flavonoid hydrogel |
CN101822275B (zh) | 2009-10-19 | 2013-05-01 | 成都中医药大学 | 一种农药组合物及其制备方法和用途 |
US20120329736A1 (en) | 2011-06-24 | 2012-12-27 | Huang Alexander L | Treatment for gastrointestinal disorders using a selective, site-activated binding system |
US20120328711A1 (en) | 2011-06-24 | 2012-12-27 | Huang Alexander L | Antimicrobial system for selective, site-activated binding at target sites |
US9192635B2 (en) | 2011-06-24 | 2015-11-24 | Liveleaf, Inc. | Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide |
US8722040B2 (en) | 2011-06-24 | 2014-05-13 | Liveleaf, Inc. | Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites |
-
2011
- 2011-06-24 US US13/135,124 patent/US8722040B2/en active Active
-
2012
- 2012-06-22 BR BR112013033125A patent/BR112013033125A8/pt not_active Application Discontinuation
- 2012-06-22 SG SG10201809283WA patent/SG10201809283WA/en unknown
- 2012-06-22 CA CA2840376A patent/CA2840376A1/en not_active Abandoned
- 2012-06-22 WO PCT/US2012/043900 patent/WO2012178127A2/en active Application Filing
- 2012-06-22 MX MX2013015439A patent/MX2013015439A/es unknown
- 2012-06-22 EP EP12802538.4A patent/EP2723334A4/en not_active Withdrawn
- 2012-06-22 MY MYPI2013702466A patent/MY189659A/en unknown
- 2012-06-22 CN CN201280031284.XA patent/CN103764141A/zh active Pending
- 2012-06-22 JP JP2014517238A patent/JP2014523883A/ja active Pending
- 2012-06-22 CN CN201710140470.1A patent/CN107126440A/zh active Pending
- 2012-06-22 KR KR1020147002126A patent/KR20140061368A/ko not_active Application Discontinuation
- 2012-06-22 AU AU2012272661A patent/AU2012272661B2/en active Active
- 2012-06-22 RU RU2014101570/15A patent/RU2014101570A/ru unknown
- 2012-06-22 EP EP19168308.5A patent/EP3569231A1/en not_active Withdrawn
-
2014
- 2014-01-22 ZA ZA2014/00532A patent/ZA201400532B/en unknown
- 2014-01-24 CO CO14014540A patent/CO6862156A2/es unknown
- 2014-03-10 US US14/203,517 patent/US8790640B1/en active Active
- 2014-04-17 US US14/255,431 patent/US20140227367A1/en not_active Abandoned
- 2014-10-22 HK HK14110531A patent/HK1197177A1/xx unknown
-
2015
- 2015-05-02 US US14/702,700 patent/US20160074435A1/en not_active Abandoned
-
2017
- 2017-01-20 JP JP2017008089A patent/JP2017110016A/ja active Pending
- 2017-07-27 AU AU2017208298A patent/AU2017208298B2/en active Active
-
2018
- 2018-03-02 HK HK18103039.7A patent/HK1243355A1/zh unknown
- 2018-06-06 PH PH12018501201A patent/PH12018501201A1/en unknown
- 2018-07-30 JP JP2018142107A patent/JP2018199682A/ja active Pending
-
2019
- 2019-10-01 US US16/589,955 patent/US20200276231A1/en not_active Abandoned
-
2022
- 2022-05-17 US US17/746,210 patent/US20230106996A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013033125A8 (pt) | Sistema de ligação que aumenta seletivamente a biotividade de compostos fenólicos em um sítio alvo; par de reagentes estabilizados para transporte aquoso a um sítio alvo; formulação farmacêutica; kit; uso do sistema; composição; e suplemento alimentar | |
GT201000160A (es) | Derivados de aminobenzamida como agentes útiles para el control de parásitos de animales | |
ES2531083T3 (es) | Formulaciones estables de polipéptidos y usos de las mismas | |
BRPI1007379B8 (pt) | composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli | |
BRPI0813450A2 (pt) | Composto, composição, combinação, formulação farmacêutica, e, métodos para inibir uma enzima, para exterminar ou prevenir o crescimento de um microorganismo e para tratar e/ou prevenir uma doença em um animal | |
CL2015001945A1 (es) | (divisional de la solicitud n° 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos. | |
CL2012000181A1 (es) | Composicion antimicrobiana para extender la vida util del agua, alimentos o ingredientes de alimentos que comprende 1% a 99% en peso de ácidos orgánicos en solucion acuosa, 0-20% de peso de terpenos y 0-5% de surfactantes; método para extender la vida util del agua, alimentos o ingredientes de alimentos. | |
BR112015006568A2 (pt) | composições e bactéria de ácido láctico | |
BR112013003045A2 (pt) | composto e composição farmacêutica e respectivos usos, recipiente estéril e método para preparar composição farmacêutica para administração | |
BR112012017564A2 (pt) | Formulação antimicrobiana | |
MXPA02002308A (es) | Composicion para el tratamiento de infecciones de humanos y animales. | |
CR11472A (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso | |
CL2008003582A1 (es) | Uso de una composicion farmaceutica que contiene cisteamina o cistamina en la preparacion de un medicamento util para el tratamiento de una enfermedad de higado graso no alcholico (nafld) o esteatohepatitis no alcoholica (nash). | |
CL2010001260A1 (es) | Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis. | |
GT200600109A (es) | Derivados de acido pirimidincarboxilico y su uso | |
BR112012006107A2 (pt) | formulações nasais, de ferida e de pele e métodos para controle de staphylococci e outras bactérias gram-positivas resistentes a antibiótico | |
EA201100899A1 (ru) | Димерные производные авермектина и милбемицина | |
AR057081A1 (es) | Medios para la fabricacion de cuero | |
SV2006002290A (es) | Nonadepsipeptidos acilados ii ref. bhc041327-sv | |
BRPI0813159A8 (pt) | Composição parasiticida veterinária, método para o tratamento ou controle de uma infecção ou infestação parasiticidas em um animal homeotérmico, e, uso de uma composição | |
MX2010002812A (es) | Composiciones alimenticias que contienen extractos de melisa. | |
HRP20190562T1 (hr) | Sastavi za liječenje zaraze srčanim crvom | |
BR112012018801A2 (pt) | composição e processo para o controle de doenças de plantas | |
BR112012006569A2 (pt) | preparados pesticidas contendo derivados de ácido pirrolidona-4-carboxílico. | |
WO2007096150A3 (en) | Organic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15I | Others concerning applications: loss of priority | ||
B12F | Other appeals [chapter 12.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: LIVELEAF HOLDINGS LLC (US) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE |
|
B08G | Application fees: restoration [chapter 8.7 patent gazette] |